Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
202 studies found for:    Open Studies | "Cardiomyopathies"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Cardiomyopathies" (202 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Device: Three-lead CRT-D (Defibrillator)
2 Recruiting A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: protein A immunoadsorption
3 Recruiting Cardiomyopathy Arrhythmia Risk Evaluation
Condition: Cardiomyopathy
Intervention:
4 Not yet recruiting Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
Condition: Cardiomyopathy
Intervention: Device: echocardiography
5 Not yet recruiting Bromocriptine in the Treatment of Peripartum Cardiomyopathy
Condition: Peripartum Cardiomyopathy
Interventions: Drug: Bromocriptine;   Other: Guideline-driven medical therapy (GDMT)
6 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
7 Not yet recruiting Peripartum Cardiomyopathy in Nigeria Registry
Condition: Peripartum Cardiomyopathy
Intervention: Drug: Oral Sodium Selenite 200 µg/day for 3 months
8 Recruiting French Hypertrophic Cardiomyopathy Observatory
Condition: Hypertrophic Cardiomyopathy
Intervention:
9 Recruiting Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Genetic: Identification of genetic polymorphisms
10 Recruiting Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy
Condition: Cardiomyopathy
Interventions: Biological: Human Mesenchymal Stem Cells (hMSCs);   Other: Standard of Care
11 Not yet recruiting The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Condition: Cardiomyopathy, Hypertrophic
Intervention:
12 Recruiting Brain fMRT In Takotsubo Cardiomyopathy
Condition: Takotsubo Cardiomyopathy
Intervention:
13 Not yet recruiting Risk Stratification of Heart Failure in Cardiomyopathies.
Condition: Cardiomyopathy With Unknown Etiology
Interventions: Drug: etiologic treatment,anti-myocardial remodeling;   Drug: anti-myocardial remodeling;   Drug: anti-myocardial remodeling,anti-acute heart failure;   Drug: Etiological, anti-remodeling and symptom treatment
14 Recruiting Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Interventions: Procedure: Noncontrast echocardiography;   Procedure: Contrast Echocardiography;   Procedure: Cardiac magnetic resonance imaging
15 Recruiting Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: CDC infusion
16 Recruiting Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Biological: Autologous stem cell therapy
17 Recruiting PHOspholamban RElated CArdiomyopathy STudy - Intervention
Condition: Phospholamban R14del Mutation-related Cardiomyopathy
Intervention: Drug: Eplerenone
18 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention
19 Recruiting Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Other: CMR using T1 mapping technique
20 Not yet recruiting Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
Condition: Ischemic Cardiomyopathy
Interventions: Biological: WJMSCs Vs. placebo;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.